Showing 1 - 10 of 495
I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …-adjusted mortality rates of residents of Germany, using longitudinal, annual, state-level data during the period 2000-2007. The estimates …-2006. The estimates imply that chemotherapy innovation accounted for at least one-sixth of the decline in French cancer …
Persistent link: https://www.econbiz.de/10013069689
Persistent link: https://www.econbiz.de/10002111184
Persistent link: https://www.econbiz.de/10009412617
Persistent link: https://www.econbiz.de/10010414357
Persistent link: https://www.econbiz.de/10009683988
latest pension legislation. As a central innovation we present a decomposition approach which allows to identify the isolated …
Persistent link: https://www.econbiz.de/10012926557
outcomes. The UK, Sweden, Canada and the US obtain the highest management scores closely followed by Germany, with a gap to …
Persistent link: https://www.econbiz.de/10013044342
environment provides a plausible framework for understanding real dollar--DM exchange rate dynamics from 1976 to 2003. The least …
Persistent link: https://www.econbiz.de/10013237961
Many countries are currently expanding access to child care for young children. But are all children equally likely to benefit from such expansions? We address this question by adopting a marginal treatment effects framework. We study the West German setting where high quality center-based care...
Persistent link: https://www.econbiz.de/10013315821
the question whether the omission of important control variables in matching estimation leads to biased impact estimates …
Persistent link: https://www.econbiz.de/10013316049